drugset

drugset / Trial / NCT00653562

Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography

NCT00653562 ↗

Phase 4 Completed 11 enrolled Astellas Pharma Inc

Non-randomizedSingle-groupSingle-blindTreatment

Summary

To evaluate the efficacy of zolpidem for adolescent insomniacs with polysomnography

Timeline

Start: 2006-11
Primary completion: 2010-03
Completion: 2010-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zolpidem	Small molecule	—	Oral

Indications